Crossmark

Clinical utility of serum concentrations of adalimumab as predictor of treatment adherence

Crossref DOI link: https://doi.org/10.1016/j.reumae.2018.01.003

Published Print: 2020-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sáez Belló, Marina

Llopis Salvia, Pilar

Alegre Sancho, Juan José

Paredes Arquiola, José María

Asencio Muñoz, M. del Carmen

Climente Martí, Mónica
License Information

Text and Data Mining valid from 2020-01-01
More Information

This article is maintained by: Elsevier

Article Title: Clinical utility of serum concentrations of adalimumab as predictor of treatment adherence

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2018.01.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2018.01.004

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.